Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, indicating a small patch or update to the page.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a version update to the page rather than a substantive change to the study information.SummaryDifference0.0%

- Check30 days agoChange DetectedDifference0.4%

- Check37 days agoChange DetectedResults Submitted indicates that study results have been submitted. The page revision has been updated to v3.5.5, replacing the previous No Results Posted status and v3.5.4 revision.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded related topics 'Schizophrenia' and a 'MedlinePlus Genetics' entry to the related topics section, expanding discoverability.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now shows Revision: v3.5.4 as the current site revision. The update also removes the related topics entries for Schizophrenia and MedlinePlus Genetics, and removes the older Revision: v3.5.3 reference.SummaryDifference0.1%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.